Selected Talks

American Society of Nephrology (ASN) Renal Week
San Francisco, CA, November, 2007
Click here to retrieve your archive of CME certificates obtained via HDCN

Nephrology Quiz and Questionnaire: Fluid and Electrolyte and Glomerular Disease Cases.
Michael Emmett, MD, and Jai Radhakrishnan, MD

Controversies in Diagnosis and Treatment of Atherosclerotic Renovascular Disease
Stephen C. Textor, MD and Lance D. Dworkin, MD, FASN

New Insights, Treatments, and Management Strategies for ADPKD
Arlene B. Chapman, MD and James P. Calvet, PhD

Novel Therapeutics for Fluid and Electrolyte Disorders
Joseph G. Verbalis, MD and Biff F. Palmer, MD

Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).

Ronald J. Hogg, MD and Alain Y. Meyrier, MD

Acute Kidney Injury. Congestive Heart Failure: A Nephrologist's Disease? (Murray) and AKI Therapeutics: From Bench to Commercialisation (Molitoris)
Patrick T. Murray, MD, FASN and Bruce A. Molitoris, MD

Renal Disease and the Metabolic Syndrome
Paul Muntner, PhD, and Linda F. Fried, MD, MPH

Physicochemical Factors in the Pathogenesis of Urinary Calculi (Worcester); Nephrolithiasis: A Bacterial Disease? Evidence Supporting and Against a Role of Nanobacteria in Calcium Stone Formation (Lieske)
Elaine M. Worcester, MD, FASN and John C. Lieske, MD, FASN

The Genetics of FSGS
Friedhelm Hildebrandt, MD, and Frederick J. Kaskel, MD, PhD, FASN

Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
James B. Froehlich, MD, MPH, and Jonathan Kay, MD

Mycophenolate in Lupus and Non-Glomerular Renal Diseases
Leslie M. Shaw, PhD and Gerald B. Appel, MD, FASN

Aldosterone: New Insights in Kidney Health and Disease
David A. Calhoun MD and Mark E. Rosenberg, MD

Pre-ESRD and Mineral Metabolism
Kevin J. Martin, MB, BCh and Sharon M. Moe, MD

New Insights into Common Problems After Kidney Transplantation
Bertram L. Kasiske, MD and Jose R. Weisinger, MD

Challenges and Opportunities in the Treatment of Hyperuricemia and Gout
Richard Johnson, MD (moderator); Robert Terkeltaub, MD; Michael W. Rich, MD; Daniel Feig, MD, PhD, MS

New Treatments for Diabetes Mellitus: Implications for Clinicians
Robert Nelson, MD and George Bakris, MD

Medical Crossfire: Managing Phosphorus in CKD -- The Challenge Remains
David Bushinsky, MD (moderator); Geoffrey Block, MD, CCRI; Francisco Llach, MD; Rajnish Mehrotra, MD, FACP, FASN.

The Aging Kidney
Danilo Fliser, MD; George R. Aronoff, MD.

Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions
Gérard M. London, MD (moderator); Craig B. Langman, MD; Markus Ketteler, MD.

Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction
John C. Burnett, MD; Michael B. Fowler, MBBS, FRCP, FACC; Mihai Gheorghiade, MD.

Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis
Norbert Lameire, MD (moderator); Pontus B. Persson, MD, PhD; Michael V. Knopp, MD, PhD; Mark A. Perazella, MD

New Developments in Anemia Management in Chronic Kidney Disease
Dr. Adeera Levin, MD (moderator): Cindy Roy, PhD; Anatole Besarab, MD; Richard Amerling, MD, Arnold Berns, MD (discussant).

Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia
Jeffrey S. Berns, MD, FASN; Robert Provenzano, MD; Lynda Szczech, MD. (Moderator: Jeffrey S. Berns, MD)
Please look also at related talks from
2006 ASN Renal Week Talks
2005 ASN Renal Week Talks
2004 ASN Renal Week Talks
2003 ASN Renal Week Talks
2002 ASN Renal Week Talks
2001 ASN Renal Week Talks
2000 ASN Renal Week Talks
1999 ASN Renal Week Talks
1998 ASN Renal Week Talks

To disseminate new knowledge regarding basic, translational, and clinical research discoveries in the field of nephrology.
To provide exciting scientific and clinical advances in related disciplines in order to expand the scope of research and clinical care in nephrology.
To discuss contemporary standards and new approaches to clinical care in order to ensure the highest quality of care for patients with renal diseases and related disorders.
To review, update and put into perspective the recent advances in many key areas of general nephrology, dialysis, transplantation, and hypertension.

See Individual Lecture Pages

Each talk, or group of talks, depending on length, is accredited for the appropriate number of AMA PRA Category 1 Credits™. Sometimes talks are organized into groups of two or more and paired with a single CME post-test, which must be completed along with an evaluation form.
Date of Web Release: See individual talks
Credit Eligible Through: April 30, 2009
Credits/Completion Time: See individual talks
Target Audiences: Physicians, researchers, trainees.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credit Designation Statement: The American Society of Nephrology designates this educational activity AMA PRA Category 1 Credits™. Physicians should only claim credit commensurat with the extent of their participation in the activity.
All lectures selected were from Renal Week 2007, and all were put together under supervision of the ASN Scientific Program Committee. Web posting of lectures in the free zone was supported by grants to the ASN from pharmaceutical companies. See each symposium page for details of industry sponsorship and support.
In accordance with the disclosure policies of the Accreditation Council for Continuing Medical Education (ACCME) and FDA guidelines, it is a policy at the ASN for individuals who are in a position to control the content of an educational activity to disclose to the activity participants: 1) the existence of all relevant financial relationships with any commercial interests or other relationships with the manufacturers of any commercial products/devices, or providers of commercial services, that relate to the content of their presentation/materials, or the commercial contributors of this activity, that could be perceived as a real or apparent conflict of interest; for this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner and 2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device not yet approved.

Based on the disclosures provided, the ASN is responsible for identifying and resolving all conflicts of interest prior to presenting the educational activity to the learner. The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

Faculty disclosures are posted on each individual talk page.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Faculty disclosure about individual talks is posted on each individual talk page.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

To complete this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player (downloadable from the Real Player from Real Media ( is required and either can be downloaded for free per instructions on the individual lecture pages. Flash 8.0 (from is required to see the full-screen slide/audio presentations and the video presentations. Acrobat Reader is required to print the CME certificate, and this can be download free from

For any questions concerning this specific activity please send an email to or, or call HDCN at 630-325-3276, Monday through Friday from 10 AM - 4 PM Central Standard Time.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.